SCHEMBL28382015

SCHEMBL28382015

CC(OCCOCCO)OC(N)=O

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.41
KMT2A Q03164 3/20 0.41
TSHR P16473 3/20 0.37
MAPK1 P28482 1/20 0.37
LMNA P02545 2/20 0.36
CHRM2 P08172 1/20 0.36
CHRM4 P08173 1/20 0.36
CHRM5 P08912 1/20 0.36
CHRM1 P11229 1/20 0.36
CHRM3 P20309 1/20 0.36
CYP2C9 P11712 1/20 0.36
MAPT P10636 2/20 0.35
THRB P10828 1/20 0.34
HTT P42858 1/20 0.34
ALDH1A1 P00352 1/20 0.32
CHRNB2 P17787 1/20 0.31
CHRNB4 P30926 1/20 0.31
CHRNA3 P32297 1/20 0.31
CHRNA4 P43681 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28528546 0.85 LMNA (0.36) MEN1KMT2ATSHRLMNACHRM2
SCHEMBL28687413 0.84 LMNA (0.35) MEN1KMT2ATSHRLMNACHRM2
SCHEMBL9463121 0.80 MEN1 (0.39) MEN1KMT2ATSHRMAPK1MAPT
SCHEMBL8634087 0.80 MEN1 (0.58) MEN1KMT2ATSHRMAPK1LMNA
SCHEMBL3340418 0.77 MEN1 (0.39) MEN1KMT2ATSHRMAPK1LMNA
SCHEMBL3339552 0.77 MEN1 (0.39) MEN1KMT2ATSHRMAPK1LMNA
SCHEMBL3342130 0.77 MEN1 (0.39) MEN1KMT2ATSHRMAPK1LMNA
SCHEMBL28513037 0.77 TSHR (0.40) TSHRLMNACHRM2CHRM4CHRM5
SCHEMBL28350438 0.77 MGMT (0.32) TSHRLMNACHRM2CHRM4CHRM5
SCHEMBL11806002 0.76 LMNA (0.41) TSHRLMNACHRM2CHRM4CHRM5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116783205-A Compounds for degradation of cyclin-dependent kinase 2 via the ubiquitin proteasome pathway 尼坎治疗公司 2023-09-19 CN disclosed
CN-113423427-A IRAK degrading agents and uses thereof 凯麦拉医疗公司 2021-09-21 CN disclosed
CN-113365662-A Method of treatment 盖纳万科学有限公司 2021-09-07 CN disclosed
CN-113226332-A Bivalent targeting conjugates 阿布特斯生物制药公司 2021-08-06 CN disclosed
CN-112105385-A IRAK degrading agents and uses thereof 凯麦拉医疗公司 2020-12-18 CN disclosed
CN-110997692-A Oligonucleotide compositions and methods of use thereof 波涛生命科学有限公司 2020-04-10 CN disclosed